Cardioplaster

History

2023: Product Announcement

Scientists at Sechenov University have developed a flexible biosensor device that will help cardiologists remotely monitor human heart failures and quickly prescribe effective treatment. The device was named "Cardioplaster," the press service of the university said on March 6, 2023.

The essence of the work of "Cardioplastic" consists in continuous removal of a single-channel electrocardiogram of the patient within 14 days. Digital medicine technologies will not replace a cardiologist, but will significantly help him in decision-making.

Cardioplaster continuously removes patient's ECG for 14 days

The device will allow you to analyze the level of physical activity of a person during rest, work, sports, monitor changes in the position of the body in space, movements and even falls. Using a mobile phone, the device will transmit data on the operation of the heart to servers in the cloud. The cardiologist will be able to connect to the system from any device, analyze the state of the cardiovascular system, compare the dynamics, track the response to load and drugs, adjust the dose of drugs and transfer recommendations to the patient's mobile application.

According to the developers, the gadget does not cause discomfort, it is miniature, flexible, wireless, waterproof, easily glued at home to the body and does not affect the patient's quality of life

The simple single-channel ECG system "Cardioplastic" is able to recognize various rhythm disorders, for example, atrial fibrillation, which increases the risk of stroke by 5-6 times. And the developed algorithms for monitoring the contractile function of the heart will allow diagnosing and assessing the course of heart failure, - said the director of the Institute of Personalized Medicine at Sechenov University.[1]

Notes